US Patent

US11179386 — Analogs of deutetrabenazine, their preparation and use

Method of Use · Assigned to Auspex Pharmaceuticals Inc · Expires 2038-03-15 · 12y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects deutetrabenazine analogs, compositions containing them, and methods for detecting them in compositions with deutetrabenazine.

USPTO Abstract

The disclosure is directed to deutetrabenazine analogs, compositions comprising same and methods of detecting same in compositions comprising deutetrabenazine.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-1995 — Austedo
U-1995 — Austedo
U-3055 — Austedo
U-1995 — Austedo
U-1995 — Austedo
U-1995 — Austedo
U-3055 — Austedo
U-3055 — Austedo
U-1995 — Austedo
U-3055 — Austedo
U-3055 — Austedo

Patent Metadata

Patent number
US11179386
Jurisdiction
US
Classification
Method of Use
Expires
2038-03-15
Drug substance claim
No
Drug product claim
Yes
Assignee
Auspex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.